IAPP and type 2 diabetes mellitus: Thus, molecular imaging could help inform treatment strategies and prognostication (e.g. in patients with type 2 diabetes, the IAPP amyloid load may act as a surrogate for β-cell loss in the pancreatic islets - [16]).